,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Toxic epidermal necrolysis,6,16628051
1,22.0,Pulmonary embolism,6,16628051
2,22.0,Radiation pneumonitis,6,16628051
3,22.0,Pneumonia,6,16628051
4,22.0,Arthralgia,6,16628051
5,22.0,Pain in extremity,6,16628051
6,22.0,Somnolence,6,16628051
7,22.0,Pain of skin,6,16628051
8,22.0,Ocular hyperaemia,6,16628051
0,22.1,Drug interaction,1,16628075
1,22.1,Hypoglycaemia,1,16628075
0,22.0,Accidental underdose,1,16628076
1,22.0,Internal haemorrhage,3,16628076
0,22.0,Death,,16628079
0,22.0,Increased appetite,,16628089
1,22.0,Dysphagia,,16628089
2,22.0,Diarrhoea,,16628089
0,22.0,Hyperglycaemia,2,16628140
0,22.0,Stress cardiomyopathy,,16628142
1,22.0,Diarrhoea,,16628142
2,22.0,Dehydration,,16628142
3,22.0,Ejection fraction decreased,,16628142
4,22.0,Supraventricular tachycardia,,16628142
5,22.0,Cardiac arrest,,16628142
6,22.0,Coronary vascular graft occlusion,,16628142
7,22.0,Myocarditis,,16628142
8,22.0,Pleural effusion,,16628142
0,22.0,Disease progression,,16628148
0,22.0,Death,,16628158
0,22.0,Dehydration,3,16628192
1,22.0,Contusion,3,16628192
0,22.0,Lipase increased,1,16628217
1,22.0,Amylase increased,1,16628217
2,22.0,Vomiting,1,16628217
3,22.0,Pancreatitis,6,16628217
4,22.0,Liver function test increased,2,16628217
5,22.0,Nausea,1,16628217
6,22.0,Abdominal discomfort,1,16628217
7,22.0,Blood glucose increased,2,16628217
0,22.0,Pyrexia,1,16628238
0,22.0,Haemoglobin decreased,3,16628368
0,22.0,Febrile neutropenia,5,16628374
0,22.0,Atrioventricular block,2,16628412
0,22.1,Intentional product use issue,6,16628467
1,22.1,Guillain-Barre syndrome,6,16628467
0,22.0,Back pain,1,16628499
1,22.0,Hypersensitivity,1,16628499
0,22.0,Death,5,16628501
0,22.0,Death,5,16628508
0,22.0,Hepatocellular injury,2,16628591
1,22.0,Cholestasis,2,16628591
0,22.0,Blood creatinine increased,5,16628607
1,22.0,Nausea,5,16628607
2,22.0,Asthenia,3,16628607
3,22.0,Hypotension,5,16628607
4,22.0,Fatigue,5,16628607
5,22.0,Dyspnoea,5,16628607
6,22.0,Decreased appetite,5,16628607
7,22.0,Hepatic function abnormal,5,16628607
8,22.0,Metastasis,5,16628607
9,22.0,Renal impairment,5,16628607
10,22.0,Sleep disorder,5,16628607
11,22.0,Haemoglobin decreased,3,16628607
12,22.0,Rectal haemorrhage,3,16628607
13,22.0,Haemorrhage,5,16628607
0,22.0,Acute kidney injury,1,16628620
1,22.0,Pneumoperitoneum,1,16628620
2,22.0,Pneumatosis intestinalis,1,16628620
3,22.0,Intestinal perforation,1,16628620
0,22.1,Pneumonia,5,16628628
1,22.1,Vascular device infection,5,16628628
0,22.0,Madarosis,3,16628651
1,22.0,Alopecia,3,16628651
0,22.0,Product dose omission,6,16628665
1,22.0,Circumstance or information capable of leading to device use error,6,16628665
2,22.0,Product availability issue,6,16628665
3,22.0,No adverse event,6,16628665
0,22.1,White blood cell count decreased,6,16628693
1,22.1,Weight decreased,6,16628693
2,22.1,Laryngitis,6,16628693
3,22.1,Flatulence,2,16628693
4,22.1,Fatigue,6,16628693
5,22.1,Alopecia,6,16628693
0,22.1,Abdominal discomfort,6,16628694
1,22.1,Malaise,6,16628694
0,22.0,White blood cell count decreased,6,16628736
1,22.0,Neoplasm progression,6,16628736
2,22.0,Bone pain,6,16628736
0,22.0,Fatigue,6,16628778
1,22.0,Decreased appetite,6,16628778
2,22.0,Fluid intake reduced,6,16628778
3,22.0,Liver function test increased,2,16628778
4,22.0,Nausea,3,16628778
0,22.1,Skull fractured base,5,16628809
1,22.1,Fall,6,16628809
0,22.0,Liver disorder,3,16628817
0,22.0,Interstitial lung disease,2,16628856
1,22.0,Pyrexia,1,16628856
0,22.0,Product quality issue,6,16628864
1,22.0,Product dose omission,6,16628864
0,22.0,Malignant neoplasm progression,5,16628914
1,22.0,Off label use,6,16628914
2,22.0,Drug ineffective for unapproved indication,6,16628914
3,22.0,Multiple organ dysfunction syndrome,5,16628914
4,22.0,Septic shock,5,16628914
0,22.0,Malignant pleural effusion,6,16628923
0,22.0,Gastrointestinal disorder,1,16628924
0,22.1,Acute kidney injury,1,16628946
1,22.1,Hyperuricaemia,1,16628946
2,22.1,Dehydration,1,16628946
0,22.0,Neutropenia,3,16628954
0,22.0,Deep vein thrombosis,1,16628975
1,22.0,Pulmonary embolism,1,16628975
0,22.0,Sjogren^s syndrome,1,16628983
1,22.0,Autoimmune hepatitis,6,16628983
0,22.1,Adrenocorticotropic hormone deficiency,6,16628984
1,22.1,Adrenal insufficiency,2,16628984
2,22.1,Off label use,6,16628984
0,22.0,Rash,3,16629035
0,22.0,Anaphylactic shock,1,16629056
0,22.1,Musculoskeletal pain,6,16629064
1,22.1,Musculoskeletal stiffness,6,16629064
2,22.1,Polyuria,6,16629064
3,22.1,Pain in extremity,6,16629064
4,22.1,Pallor,6,16629064
5,22.1,Dysphagia,6,16629064
6,22.1,Thirst,6,16629064
7,22.1,Hypothalamo-pituitary disorder,1,16629064
8,22.1,Cachexia,6,16629064
9,22.1,Oedema peripheral,6,16629064
0,22.0,Thrombosis,6,16629084
1,22.0,Gait inability,6,16629084
0,22.1,Hot flush,1,16629122
1,22.1,Diarrhoea,3,16629122
2,22.1,Dyspnoea,3,16629122
3,22.1,Nausea,6,16629122
4,22.1,Productive cough,3,16629122
5,22.1,Abdominal discomfort,1,16629122
6,22.1,Transaminases increased,1,16629122
7,22.1,Off label use,6,16629122
8,22.1,Nausea,1,16629122
0,22.0,Pneumothorax,1,16629147
0,22.0,Gastrointestinal disorder,6,16629217
1,22.0,Bone marrow failure,6,16629217
2,22.0,Cardiotoxicity,6,16629217
0,22.0,Rash,6,16629245
1,22.0,Diarrhoea,6,16629245
2,22.0,Hepatic function abnormal,6,16629245
0,22.0,Nephropathy toxic,6,16629285
1,22.0,Diarrhoea,6,16629285
2,22.0,Thrombocytopenia,6,16629285
3,22.0,Nausea,6,16629285
4,22.0,Liver injury,6,16629285
5,22.0,Anaemia,6,16629285
6,22.0,Neutropenia,6,16629285
7,22.0,Leukopenia,6,16629285
8,22.0,Vomiting,6,16629285
0,22.0,Neuropathy peripheral,,16629298
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16629298
2,22.0,Decreased appetite,,16629298
3,22.0,Off label use,,16629298
0,22.1,Stevens-Johnson syndrome,1,16629305
0,22.1,Leukopenia,6,16629312
1,22.1,Fatigue,6,16629312
2,22.1,Inappropriate schedule of product administration,6,16629312
3,22.1,Product dose omission,6,16629312
0,22.0,Osteonecrosis,3,16629327
1,22.0,Off label use,6,16629327
2,22.0,Stress fracture,3,16629327
0,22.0,Cerebral haemorrhage,6,16629366
1,22.0,Fall,6,16629366
2,22.0,Contusion,6,16629366
3,22.0,Central nervous system necrosis,6,16629366
4,22.0,Platelet count decreased,6,16629366
0,22.0,Progressive multifocal leukoencephalopathy,5,16629382
0,22.0,Urticaria,1,16629428
0,22.0,Rash generalised,1,16629442
1,22.0,Stomatitis,2,16629442
2,22.0,Rash pruritic,1,16629442
3,22.0,Eye swelling,2,16629442
4,22.0,Swelling face,2,16629442
0,22.1,Neuropathy peripheral,3,16629473
1,22.1,Blood pressure increased,3,16629473
2,22.1,Gait disturbance,6,16629473
3,22.1,Feeling abnormal,6,16629473
0,22.0,Fatigue,6,16629478
1,22.0,Nausea,6,16629478
2,22.0,Dizziness,6,16629478
3,22.0,Decreased appetite,6,16629478
0,22.1,Sciatica,6,16629538
1,22.1,Dizziness,6,16629538
2,22.1,Fatigue,6,16629538
3,22.1,Nerve compression,6,16629538
0,22.0,Gait disturbance,1,16629540
1,22.0,Asthenia,3,16629540
2,22.0,Muscle atrophy,3,16629540
0,22.0,Oesophagobronchial fistula,6,16629618
1,22.0,Pneumonia,1,16629618
2,22.0,Diffuse panbronchiolitis,6,16629618
0,22.0,Neutropenic sepsis,6,16629676
0,22.0,Interstitial lung disease,2,16629678
1,22.0,Lung disorder,1,16629678
0,22.0,Stomatitis,6,16629680
1,22.0,Rash,6,16629680
0,22.0,Contusion,6,16629683
1,22.0,Fatigue,6,16629683
2,22.0,Rash,2,16629683
3,22.0,Nausea,6,16629683
4,22.0,Urine odour abnormal,6,16629683
5,22.0,White blood cell count decreased,3,16629683
6,22.0,Dysgeusia,6,16629683
7,22.0,Hypersensitivity,6,16629683
0,22.0,Acute kidney injury,1,16629693
0,22.0,Nausea,1,16629696
1,22.0,Malaise,6,16629696
2,22.0,Pyrexia,1,16629696
3,22.0,Myalgia,1,16629696
4,22.0,Abdominal pain upper,1,16629696
5,22.0,Fatigue,6,16629696
6,22.0,Chills,1,16629696
0,22.1,Headache,3,16629707
1,22.1,Lymphadenopathy,3,16629707
2,22.1,Blood count abnormal,6,16629707
3,22.1,Pain in jaw,3,16629707
4,22.1,Stomatitis,3,16629707
5,22.1,Influenza like illness,1,16629707
6,22.1,Cough,3,16629707
7,22.1,Constipation,3,16629707
8,22.1,Toothache,3,16629707
9,22.1,Product dose omission,6,16629707
10,22.1,Rhinorrhoea,3,16629707
11,22.1,Hot flush,1,16629707
12,22.1,Bone marrow failure,3,16629707
13,22.1,Neutropenia,3,16629707
14,22.1,Lip ulceration,3,16629707
15,22.1,Pain,3,16629707
16,22.1,Pyrexia,1,16629707
17,22.1,Fatigue,3,16629707
18,22.1,Sinus disorder,3,16629707
19,22.1,White blood cell count decreased,3,16629707
20,22.1,Alopecia,3,16629707
21,22.1,Dyspnoea,3,16629707
22,22.1,Leukopenia,3,16629707
23,22.1,Lymph node pain,3,16629707
24,22.1,Sinus congestion,3,16629707
25,22.1,Oropharyngeal pain,3,16629707
26,22.1,Nausea,1,16629707
27,22.1,Periorbital swelling,3,16629707
28,22.1,Insomnia,3,16629707
29,22.1,Neoplasm progression,1,16629707
0,22.0,Constipation,6,16629718
0,22.0,Hepatotoxicity,6,16629773
1,22.0,Transaminases increased,6,16629773
2,22.0,Blood bilirubin increased,6,16629773
0,22.0,Ileus paralytic,6,16629777
0,22.1,Neutropenia,6,16629813
1,22.1,Lethargy,6,16629813
2,22.1,Bone lesion,6,16629813
3,22.1,Arthralgia,6,16629813
4,22.1,Nausea,1,16629813
0,22.0,Angina pectoris,6,16629821
1,22.0,Ejection fraction decreased,6,16629821
2,22.0,Electrocardiogram abnormal,6,16629821
0,22.0,Malaise,1,16629837
1,22.0,Loss of consciousness,1,16629837
0,22.0,Dry skin,2,16629844
1,22.0,Dysphagia,3,16629844
2,22.0,Infection,3,16629844
0,22.0,Metastases to bone,6,16629849
1,22.0,Breast cancer metastatic,6,16629849
2,22.0,PIK3CA-activated mutation,6,16629849
3,22.0,Malignant neoplasm progression,6,16629849
0,22.0,Device defective,6,16629850
1,22.0,Accidental exposure to product,6,16629850
0,22.0,Osteoporosis,6,16629856
1,22.0,Injection site pain,6,16629856
0,22.0,Deafness bilateral,6,16629859
1,22.0,Meningitis,6,16629859
2,22.0,Intentional product use issue,6,16629859
3,22.0,Thyroiditis,6,16629859
0,22.0,General physical health deterioration,6,16629863
0,22.0,Malaise,3,16629873
0,22.0,Impaired gastric emptying,6,16629883
0,22.0,Ototoxicity,6,16629886
1,22.0,Intentional product use issue,6,16629886
0,22.0,Mucous stools,6,16629927
1,22.0,Haematochezia,6,16629927
2,22.0,Decreased appetite,6,16629927
3,22.0,Eye pain,6,16629927
4,22.0,Nausea,6,16629927
5,22.0,Gait disturbance,6,16629927
6,22.0,Cough,6,16629927
7,22.0,Ocular hyperaemia,6,16629927
8,22.0,Diarrhoea,6,16629927
9,22.0,Fatigue,6,16629927
10,22.0,Vomiting,6,16629927
11,22.0,Dyspnoea,6,16629927
12,22.0,Vision blurred,6,16629927
13,22.0,Balance disorder,6,16629927
0,22.0,Liver disorder,6,16629937
0,22.0,Cholecystitis,3,16629938
0,22.0,Varicose veins of abdominal wall,6,16629971
1,22.0,Superior vena cava stenosis,6,16629971
2,22.0,Neoplasm,6,16629971
3,22.0,Collateral circulation,6,16629971
0,22.0,Death,5,16630020
0,22.0,Abdominal wall haematoma,3,16630023
1,22.0,Intestinal obstruction,3,16630023
2,22.0,Product use complaint,3,16630023
3,22.0,Prostatic specific antigen increased,3,16630023
4,22.0,Oedema,3,16630023
0,22.0,Gravitational oedema,1,16630056
1,22.0,Neutropenia,1,16630056
2,22.0,Pyrexia,1,16630056
0,22.0,Ileus,1,16630058
0,22.0,Death,5,16630063
0,22.0,Death,5,16630079
1,22.0,Off label use,6,16630079
0,22.0,Skin toxicity,6,16630106
1,22.0,Off label use,6,16630106
2,22.0,Death,5,16630106
0,22.0,Bone marrow failure,1,16630111
0,22.1,Pain in extremity,1,16630139
1,22.1,Arthralgia,3,16630139
2,22.1,Groin pain,3,16630139
0,22.0,Off label use,6,16630143
1,22.0,Death,5,16630143
0,22.0,Febrile neutropenia,1,16630149
0,22.0,Diarrhoea,3,16630251
1,22.0,Vomiting,3,16630251
2,22.0,Liver injury,6,16630251
3,22.0,Dyspepsia,6,16630251
4,22.0,Muscle spasms,6,16630251
5,22.0,Nausea,3,16630251
6,22.0,Abdominal pain,6,16630251
0,22.0,Breast cancer metastatic,6,16630252
1,22.0,Diarrhoea,6,16630252
2,22.0,Death,5,16630252
3,22.0,Dehydration,6,16630252
4,22.0,Off label use,6,16630252
0,22.1,Malaise,6,16630269
1,22.1,Gastritis,6,16630269
0,22.1,Neutropenia,1,16630294
1,22.1,Febrile infection,1,16630294
2,22.1,Leukopenia,1,16630294
3,22.1,Neutropenia,1,16630294
4,22.1,Nausea,1,16630294
5,22.1,Depression,6,16630294
6,22.1,Leukopenia,1,16630294
7,22.1,Leukopenia,1,16630294
8,22.1,C-reactive protein increased,1,16630294
9,22.1,Leukopenia,6,16630294
10,22.1,Neutropenia,1,16630294
11,22.1,Nausea,1,16630294
12,22.1,Pneumonia,1,16630294
0,22.0,Intentional product use issue,6,16630296
1,22.0,Off label use,6,16630296
2,22.0,Death,5,16630296
0,22.0,Granulocytopenia,3,16630301
0,22.1,Urticaria,1,16630324
0,22.1,Pulmonary oedema,5,16630331
0,22.0,Colitis,1,16630351
1,22.0,Aspergillus infection,2,16630351
0,22.0,Erythema,1,16630407
0,22.0,Terminal state,6,16630408
0,22.0,Off label use,6,16630444
1,22.0,Death,5,16630444
0,22.0,Off label use,6,16630460
1,22.0,Death,5,16630460
2,22.0,Skin toxicity,6,16630460
0,22.1,Cornea verticillata,6,16630534
0,22.0,Blood creatinine increased,1,16630552
0,22.0,Castleman^s disease,6,16630560
1,22.0,Haemophagocytic lymphohistiocytosis,6,16630560
0,22.0,Pneumonia,5,16630597
0,22.0,Alanine aminotransferase increased,6,16630602
0,22.1,Malignant neoplasm progression,5,16630607
1,22.1,Off label use,6,16630607
2,22.1,Haemorrhoids,6,16630607
3,22.1,Gait disturbance,6,16630607
0,22.0,Gastrointestinal perforation,3,16630621
0,22.0,Metastases to ovary,6,16630628
1,22.0,Metastases to liver,6,16630628
0,22.0,Renal haematoma,6,16630637
0,22.0,Drug intolerance,6,16630646
0,22.0,Dyspnoea,4,16630666
0,22.1,Anaemia macrocytic,6,16630684
1,22.1,Carcinoma in situ,1,16630684
2,22.1,Malaise,6,16630684
3,22.1,Normocytic anaemia,6,16630684
4,22.1,Interstitial lung disease,3,16630684
5,22.1,Anaemia,1,16630684
6,22.1,Vomiting,6,16630684
7,22.1,Platelet count decreased,1,16630684
8,22.1,Nausea,6,16630684
0,22.0,Nausea,3,16630693
1,22.0,Vomiting,3,16630693
2,22.0,Asthenia,3,16630693
3,22.0,Pharyngeal paraesthesia,2,16630693
4,22.0,Paraesthesia,3,16630693
5,22.0,Dyspnoea,2,16630693
6,22.0,Accidental overdose,6,16630693
7,22.0,Product prescribing error,6,16630693
8,22.0,Product communication issue,6,16630693
9,22.0,Cramp-fasciculation syndrome,2,16630693
10,22.0,Wrong strength,6,16630693
0,22.0,Pruritus,1,16630704
1,22.0,Hypotension,1,16630704
2,22.0,Erythema,1,16630704
0,22.0,Neurotoxicity,2,16630706
1,22.0,Ovarian cancer recurrent,6,16630706
0,22.1,Drug interaction,6,16630711
1,22.1,Feeling hot,6,16630711
2,22.1,Pain in extremity,6,16630711
3,22.1,Fatigue,6,16630711
0,22.0,Off label use,6,16630716
1,22.0,Wrong technique in product usage process,6,16630716
0,22.0,Pneumonia,1,16630786
1,22.0,Dehydration,1,16630786
0,22.1,Vomiting,6,16630789
1,22.1,Gastric mucosal hypertrophy,6,16630789
2,22.1,Decreased appetite,6,16630789
0,22.0,Malignant neoplasm progression,5,16630799
1,22.0,Malaise,6,16630799
2,22.0,Deep vein thrombosis,6,16630799
3,22.0,Cerebral infarction,6,16630799
4,22.0,Retinal artery occlusion,6,16630799
5,22.0,Pulmonary embolism,6,16630799
0,22.0,Death,5,16630814
1,22.0,Intentional product use issue,6,16630814
0,22.1,Lymphoma,6,16630831
0,22.0,Dysphagia,6,16630857
0,22.0,Constipation,6,16630870
1,22.0,Abdominal pain,1,16630870
2,22.0,Colitis ischaemic,6,16630870
3,22.0,Product use issue,6,16630870
4,22.0,Hyponatraemia,1,16630870
0,22.0,Stomatitis,6,16630906
1,22.0,Cerebral infarction,6,16630906
2,22.0,Neurologic neglect syndrome,6,16630906
3,22.0,Chronic kidney disease,6,16630906
4,22.0,Trousseau^s syndrome,6,16630906
5,22.0,Movement disorder,6,16630906
6,22.0,Deep vein thrombosis,6,16630906
7,22.0,Aphasia,6,16630906
8,22.0,Depressed level of consciousness,2,16630906
0,22.0,Neutropenia,2,16630918
1,22.0,Platelet count decreased,6,16630918
0,22.0,Haemoglobin decreased,6,16630985
1,22.0,Malignant neoplasm progression,5,16630985
2,22.0,Depressed mood,6,16630985
3,22.0,Breast cancer metastatic,5,16630985
4,22.0,Decreased appetite,6,16630985
5,22.0,Platelet count decreased,6,16630985
6,22.0,Respiratory failure,5,16630985
7,22.0,Asthenia,6,16630985
0,22.0,Pneumonia,6,16630992
1,22.0,Malaise,1,16630992
2,22.0,Dizziness,1,16630992
3,22.0,Ill-defined disorder,6,16630992
0,22.1,Nausea,1,16630995
1,22.1,General physical health deterioration,1,16630995
2,22.1,Thrombocytopenia,1,16630995
3,22.1,Leukopenia,2,16630995
4,22.1,Neutropenia,2,16630995
5,22.1,Eastern Cooperative Oncology Group performance status worsened,3,16630995
6,22.1,Vomiting,1,16630995
0,22.0,Death,5,16631023
0,22.0,Anaemia,3,16631043
1,22.0,Thrombocytopenia,3,16631043
0,22.0,Fatigue,6,16631054
1,22.0,Blood urine present,6,16631054
2,22.0,Blood pressure increased,6,16631054
3,22.0,Death,5,16631054
4,22.0,Vomiting,6,16631054
0,22.0,Small intestinal obstruction,1,16631177
0,22.0,Blood count abnormal,6,16631256
0,22.0,Type 2 diabetes mellitus,2,16631369
0,22.0,Fatigue,6,16631380
1,22.0,Gastrooesophageal reflux disease,6,16631380
2,22.0,Pancytopenia,6,16631380
3,22.0,Nausea,6,16631380
4,22.0,Asthenia,6,16631380
5,22.0,Malaise,6,16631380
0,22.0,Dyspepsia,1,16631396
1,22.0,Nausea,1,16631396
2,22.0,Decreased appetite,1,16631396
3,22.0,Neutropenia,1,16631396
4,22.0,Lymphopenia,1,16631396
5,22.0,Dizziness,1,16631396
6,22.0,Renal failure,1,16631396
7,22.0,Thrombocytopenia,1,16631396
8,22.0,Leukopenia,1,16631396
9,22.0,Hyperglycaemia,1,16631396
10,22.0,Diarrhoea,1,16631396
11,22.0,Hypertension,1,16631396
12,22.0,Myalgia,1,16631396
13,22.0,Vomiting,1,16631396
14,22.0,Epistaxis,1,16631396
15,22.0,Headache,1,16631396
16,22.0,Liver disorder,1,16631396
0,22.0,Decreased appetite,1,16631402
1,22.0,Abdominal pain upper,1,16631402
2,22.0,Mucosal inflammation,1,16631402
3,22.0,Hypertension,1,16631402
4,22.0,Renal failure,1,16631402
5,22.0,Back pain,1,16631402
6,22.0,Swelling of eyelid,1,16631402
7,22.0,Thrombocytopenia,1,16631402
8,22.0,Neutropenia,1,16631402
9,22.0,Nausea,1,16631402
10,22.0,Hypothyroidism,1,16631402
11,22.0,Constipation,1,16631402
12,22.0,Joint swelling,1,16631402
13,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16631402
14,22.0,Dyspepsia,1,16631402
15,22.0,Oedema,1,16631402
16,22.0,Gout,1,16631402
17,22.0,Arthralgia,1,16631402
18,22.0,Taste disorder,1,16631402
19,22.0,Dehydration,1,16631402
20,22.0,Oedema peripheral,1,16631402
21,22.0,Blister,1,16631402
22,22.0,Leukopenia,1,16631402
23,22.0,Stomatitis,1,16631402
24,22.0,Diarrhoea,1,16631402
25,22.0,Myalgia,1,16631402
26,22.0,Lymphopenia,1,16631402
27,22.0,Anaemia,1,16631402
0,22.1,Diarrhoea,1,16631413
1,22.1,Vomiting,1,16631413
2,22.1,Acute kidney injury,1,16631413
3,22.1,Decreased appetite,3,16631413
4,22.1,Cholelithiasis,3,16631413
5,22.1,Back pain,3,16631413
6,22.1,Rash pruritic,1,16631413
7,22.1,Condition aggravated,3,16631413
8,22.1,Rectal haemorrhage,3,16631413
9,22.1,Weight decreased,3,16631413
10,22.1,Hypomagnesaemia,1,16631413
0,22.0,Off label use,6,16631416
1,22.0,Ill-defined disorder,6,16631416
2,22.0,Product use in unapproved indication,6,16631416
0,22.0,Renal impairment,3,16631417
1,22.0,Blood glucose abnormal,3,16631417
0,22.0,Central nervous system neoplasm,6,16631446
0,22.0,Oedema peripheral,6,16631462
0,22.0,Diverticulum intestinal,6,16631468
1,22.0,Gastrointestinal haemorrhage,6,16631468
0,22.1,Abdominal pain upper,1,16631488
1,22.1,Wrong technique in product usage process,6,16631488
2,22.1,Transient ischaemic attack,1,16631488
3,22.1,Hypertension,1,16631488
4,22.1,Blister,1,16631488
0,22.0,Purpura,6,16631494
1,22.0,Deep vein thrombosis,6,16631494
0,22.0,Lung disorder,5,16631545
1,22.0,Infection,6,16631545
2,22.0,Acute respiratory failure,5,16631545
3,22.0,Radiation pneumonitis,5,16631545
4,22.0,Pneumonia,5,16631545
5,22.0,Back pain,6,16631545
0,22.1,Infection,5,16631556
1,22.1,Hip fracture,2,16631556
2,22.1,Fall,2,16631556
0,22.0,Escherichia urinary tract infection,6,16631589
0,22.0,Pelvic deformity,6,16631633
1,22.0,Confusional state,6,16631633
2,22.0,Intentional product use issue,6,16631633
3,22.0,Pyrexia,2,16631633
4,22.0,Intestinal perforation,3,16631633
0,22.0,Blood thyroid stimulating hormone increased,3,16631672
1,22.0,Headache,3,16631672
0,22.0,Weight decreased,3,16631711
1,22.0,Fatigue,6,16631711
2,22.0,Abdominal discomfort,6,16631711
3,22.0,Diarrhoea,6,16631711
0,22.0,Fatigue,6,16631713
1,22.0,Arthralgia,6,16631713
2,22.0,Balance disorder,6,16631713
3,22.0,Neoplasm progression,6,16631713
4,22.0,Essential hypertension,6,16631713
0,22.1,Drug ineffective,6,16631869
0,22.0,Seizure,6,16631874
1,22.0,Diarrhoea,6,16631874
2,22.0,Abdominal pain upper,6,16631874
0,22.0,Hypophagia,6,16631881
1,22.0,Thrombosis,6,16631881
0,22.0,Off label use,6,16631890
1,22.0,Chronic obstructive pulmonary disease,6,16631890
2,22.0,Respiratory tract infection,6,16631890
3,22.0,Interstitial lung disease,6,16631890
0,22.0,Pyrexia,1,16631963
1,22.0,Fatigue,1,16631963
2,22.0,Oropharyngeal pain,1,16631963
3,22.0,Gastroenteritis viral,1,16631963
4,22.0,Nasopharyngitis,1,16631963
5,22.0,Headache,1,16631963
6,22.0,Diarrhoea,1,16631963
7,22.0,Catheter site bruise,1,16631963
8,22.0,Neuropathy peripheral,1,16631963
9,22.0,Myalgia,1,16631963
10,22.0,Arthralgia,1,16631963
11,22.0,Mucosal inflammation,1,16631963
12,22.0,Cough,1,16631963
13,22.0,Vomiting,1,16631963
14,22.0,Decreased appetite,1,16631963
0,22.0,Hip fracture,6,16631999
1,22.0,Hypercalcaemia,6,16631999
2,22.0,Confusional state,6,16631999
3,22.0,Anaemia,6,16631999
4,22.0,Hypophagia,6,16631999
0,22.0,Pruritus,1,16632009
1,22.0,Leukopenia,3,16632009
2,22.0,Neuropathy peripheral,1,16632009
3,22.0,Nausea,6,16632009
0,22.0,Asthenia,3,16632019
1,22.0,Confusional state,3,16632019
0,22.0,Fatigue,6,16632022
1,22.0,Hypersensitivity,6,16632022
2,22.0,Nasal congestion,6,16632022
3,22.0,Abdominal pain,6,16632022
4,22.0,Thyroid disorder,6,16632022
5,22.0,Constipation,6,16632022
0,22.0,Drug ineffective,6,16632052
0,22.0,Diarrhoea,2,16632099
0,22.0,Pancytopenia,2,16632108
1,22.0,Asthenia,2,16632108
0,22.1,Acute febrile neutrophilic dermatosis,2,16632162
0,22.0,Haemorrhagic diathesis,3,16632173
1,22.0,Insomnia,3,16632173
0,22.0,Expired product administered,6,16632291
1,22.0,Thyroid disorder,6,16632291
2,22.0,Rash,6,16632291
3,22.0,Gait disturbance,1,16632291
4,22.0,Reaction to colouring,6,16632291
5,22.0,Chest pain,6,16632291
6,22.0,Back pain,6,16632291
7,22.0,Asthenia,1,16632291
8,22.0,Fatigue,6,16632291
0,22.0,Blister,3,16632294
0,22.0,Hepatocellular injury,2,16632639
0,22.0,Dyspnoea,2,16632684
1,22.0,Oxygen saturation decreased,2,16632684
0,22.0,Cardiac failure acute,1,16632730
1,22.0,Electrocardiogram QT prolonged,1,16632730
2,22.0,Blood pressure increased,6,16632730
0,22.0,Bronchitis,1,16632765
1,22.0,Adrenal disorder,6,16632765
2,22.0,Drug resistance,6,16632765
0,22.0,Drug interaction,6,16632829
1,22.0,Angina pectoris,4,16632829
2,22.0,Pancytopenia,4,16632829
0,22.0,Madarosis,3,16632861
1,22.0,Alopecia,3,16632861
0,22.1,White blood cell count decreased,3,16632883
1,22.1,Product dose omission,6,16632883
2,22.1,Decreased appetite,3,16632883
3,22.1,Alopecia,3,16632883
4,22.1,Nail disorder,3,16632883
5,22.1,Extra dose administered,6,16632883
6,22.1,Gastrointestinal motility disorder,6,16632883
0,22.0,Alopecia,6,16632924
1,22.0,Anaemia,6,16632924
2,22.0,Asthenia,6,16632924
0,22.0,Erysipelas,1,16633034
1,22.0,Neuritis cranial,1,16633034
0,22.0,Thrombocytopenia,1,16633051
0,22.0,Macular oedema,1,16633062
0,22.0,Metastases to stomach,6,16633070
1,22.0,Breast cancer recurrent,6,16633070
2,22.0,Malignant neoplasm progression,6,16633070
3,22.0,Hepatotoxicity,6,16633070
4,22.0,Drug ineffective,6,16633070
0,22.0,Hepatocellular injury,2,16633083
1,22.0,Cholestasis,2,16633083
0,22.0,Death,5,16633174
0,22.0,Decreased appetite,6,16633177
1,22.0,Rash,3,16633177
2,22.0,Pyrexia,3,16633177
3,22.0,Haematochezia,2,16633177
4,22.0,Diarrhoea,6,16633177
0,22.0,Interstitial lung disease,2,16633326
1,22.0,Pyrexia,1,16633326
2,22.0,Pneumonia bacterial,6,16633326
0,22.0,Muscular weakness,2,16633364
1,22.0,Facial paralysis,2,16633364
2,22.0,Troponin T increased,2,16633364
3,22.0,Arrhythmia,2,16633364
4,22.0,Ventricular extrasystoles,2,16633364
5,22.0,Product use in unapproved indication,6,16633364
0,22.0,Fall,6,16633490
1,22.0,Hair colour changes,6,16633490
2,22.0,Intestinal haemorrhage,6,16633490
3,22.0,Constipation,6,16633490
4,22.0,Gastrointestinal disorder,6,16633490
5,22.0,Internal haemorrhage,6,16633490
6,22.0,Pigmentation disorder,6,16633490
0,22.0,Nausea,,16633521
1,22.0,Fatigue,,16633521
2,22.0,Hypertension,,16633521
0,22.0,Malignant neoplasm progression,6,16633544
0,22.0,Therapy cessation,,16633564
1,22.0,Hospitalisation,,16633564
0,22.0,Fall,,16633596
1,22.0,Nausea,,16633596
2,22.0,Dehydration,,16633596
3,22.0,Diarrhoea,,16633596
0,22.0,Drug intolerance,,16633605
0,22.0,Anaemia,1,16633612
0,22.0,Asthenia,1,16633634
1,22.0,Anuria,1,16633634
0,22.0,Lung infection,6,16633640
0,22.0,Neoplasm malignant,,16633647
0,22.1,Hypertension,1,16633659
0,22.0,Disease progression,,16633693
0,22.0,Vitreous floaters,,16633727
1,22.0,Retinal tear,,16633727
0,22.1,Blood uric acid increased,6,16633814
1,22.1,Pleural effusion,6,16633814
2,22.1,Blood lactate dehydrogenase increased,6,16633814
3,22.1,Arrhythmia,6,16633814
4,22.1,Pneumonia,6,16633814
5,22.1,Blood potassium increased,6,16633814
0,22.1,Type 2 diabetes mellitus,4,16633820
0,22.0,Nausea,6,16633862
1,22.0,Fatigue,6,16633862
2,22.0,Off label use,6,16633862
0,22.0,Malignant neoplasm progression,6,16633978
1,22.0,Pneumonitis,1,16633978
0,22.0,Immune-mediated adverse reaction,2,16633995
1,22.0,Product use in unapproved indication,6,16633995
2,22.0,Immune-mediated pneumonitis,6,16633995
3,22.0,Myocarditis,2,16633995
0,22.0,Cerebral infarction,6,16634017
1,22.0,Arthralgia,6,16634017
2,22.0,Drug resistance,6,16634017
3,22.0,Malignant neoplasm progression,6,16634017
4,22.0,Weight increased,6,16634017
0,22.0,Interstitial lung disease,5,16634018
0,22.0,Cardiac failure acute,2,16634022
1,22.0,Tachyarrhythmia,5,16634022
2,22.0,Pulmonary oedema,2,16634022
3,22.0,Supraventricular tachycardia,2,16634022
4,22.0,Cardiac failure,5,16634022
5,22.0,Radiation pneumonitis,3,16634022
0,22.1,Metastases to bone,6,16634044
1,22.1,White blood cell count decreased,6,16634044
2,22.1,Malignant neoplasm progression,6,16634044
0,22.0,Peripheral sensory neuropathy,1,16634045
1,22.0,Urinary tract infection,1,16634045
2,22.0,Pyrexia,1,16634045
0,22.0,Blood urine present,6,16634062
1,22.0,Confusional state,6,16634062
2,22.0,Dyspnoea,6,16634062
3,22.0,Asthenia,6,16634062
0,22.1,Oestrogen receptor assay positive,6,16634071
1,22.1,Pulmonary mass,1,16634071
2,22.1,Off label use,6,16634071
3,22.1,Drug ineffective,6,16634071
4,22.1,Intentional product use issue,6,16634071
0,22.0,Vomiting,5,16634072
1,22.0,Neurological decompensation,5,16634072
2,22.0,Metastases to central nervous system,5,16634072
3,22.0,Headache,5,16634072
4,22.0,General physical health deterioration,5,16634072
5,22.0,Neoplasm progression,5,16634072
0,22.0,Ejection fraction decreased,6,16634095
0,22.0,Amylase increased,6,16634104
0,22.0,Death,5,16634144
1,22.0,Dyspepsia,6,16634144
0,22.1,Diabetes mellitus,1,16634145
0,22.0,Hypocalcaemia,2,16634164
1,22.0,Diarrhoea,3,16634164
2,22.0,Hypomagnesaemia,2,16634164
3,22.0,Hypokalaemia,2,16634164
0,22.0,Breast cancer metastatic,6,16634185
0,22.0,Cutaneous sarcoidosis,3,16634191
1,22.0,Pulmonary sarcoidosis,3,16634191
0,22.1,Nasopharyngitis,6,16634243
1,22.1,Transaminases increased,6,16634243
2,22.1,Lower limb fracture,6,16634243
0,22.0,Tremor,6,16634275
0,22.1,Cardiomyopathy,2,16634320
1,22.1,Pneumonia,2,16634320
0,22.0,Small intestinal perforation,6,16634402
1,22.0,Proteinuria,6,16634402
2,22.0,Nephrotic syndrome,6,16634402
3,22.0,Infection,6,16634402
4,22.0,Gastrointestinal toxicity,6,16634402
5,22.0,Hypertension,6,16634402
6,22.0,Intestinal obstruction,6,16634402
0,22.1,Contusion,5,16634418
1,22.1,Cerebral haemorrhage,5,16634418
2,22.1,Fall,6,16634418
0,22.0,Pyrexia,1,16634479
1,22.0,Myalgia,1,16634479
2,22.0,Chills,1,16634479
3,22.0,Nausea,1,16634479
4,22.0,Abdominal pain upper,1,16634479
5,22.0,Malaise,6,16634479
6,22.0,Fatigue,6,16634479
0,22.0,Pneumocystis jirovecii pneumonia,2,16634483
1,22.0,Interstitial lung disease,6,16634483
0,22.1,Pain in extremity,1,16634484
1,22.1,Groin pain,3,16634484
0,22.0,Central nervous system neoplasm,6,16634522
0,22.0,Chorea,3,16634523
0,22.0,Sympathetic ophthalmia,1,16634525
1,22.0,Choroidal detachment,1,16634525
2,22.0,Product use in unapproved indication,6,16634525
0,22.0,Renal impairment,1,16634560
1,22.0,Blood creatine increased,1,16634560
0,22.0,Embolism,1,16634580
0,22.0,Cholestasis,1,16634644
0,22.0,Cholestasis,2,16634659
0,22.0,Hepatic function abnormal,5,16634670
1,22.0,Ascites,3,16634670
2,22.0,Hepatic atrophy,3,16634670
3,22.0,Hepatic cirrhosis,5,16634670
0,22.0,Chills,2,16634673
1,22.0,Nausea,2,16634673
2,22.0,Vomiting,2,16634673
3,22.0,Muscle tightness,2,16634673
4,22.0,Headache,2,16634673
5,22.0,Myalgia,2,16634673
6,22.0,Musculoskeletal stiffness,2,16634673
0,22.0,Acute myeloid leukaemia,3,16634684
0,22.0,Cardiac dysfunction,5,16634763
1,22.0,Cardiomyopathy,5,16634763
2,22.0,Ventricular arrhythmia,5,16634763
3,22.0,Arrhythmogenic right ventricular dysplasia,5,16634763
0,22.1,Aortic dissection,1,16634765
1,22.1,Aortitis,1,16634765
0,22.0,Deafness,1,16634816
1,22.0,Central nervous system lesion,3,16634816
2,22.0,Cerebrovascular accident,6,16634816
3,22.0,Blindness,1,16634816
0,22.0,Death,5,16634823
0,22.0,Pruritus,1,16634841
1,22.0,Hot flush,6,16634841
2,22.0,Pyrexia,6,16634841
3,22.0,Rash,1,16634841
0,22.0,Neuropathy peripheral,6,16634844
1,22.0,Cancer pain,6,16634844
0,22.0,Vascular device infection,1,16634954
0,22.0,Cerebral infarction,6,16635026
1,22.0,Vasculitis,6,16635026
0,22.0,Platelet count decreased,6,16635033
0,22.0,Renal impairment,2,16635043
1,22.0,Decreased appetite,2,16635043
0,22.0,Acute left ventricular failure,5,16635060
1,22.0,Dyspnoea,6,16635060
2,22.0,Death,5,16635060
3,22.0,Heart rate irregular,6,16635060
4,22.0,Myocardial necrosis marker increased,6,16635060
5,22.0,Cardiac dysfunction,6,16635060
6,22.0,Hydrothorax,6,16635060
7,22.0,Diarrhoea,6,16635060
8,22.0,Myocardial infarction,6,16635060
0,22.0,Device related infection,2,16635078
1,22.0,Pain,3,16635078
0,22.0,Product dose omission,6,16635079
1,22.0,Malignant neoplasm progression,6,16635079
2,22.0,Device issue,6,16635079
0,22.0,Dyspnoea,5,16635081
0,22.0,Pain,6,16635159
1,22.0,Polyneuropathy,6,16635159
2,22.0,Proteinuria,6,16635159
3,22.0,Cholecystitis chronic,6,16635159
4,22.0,Neoplasm recurrence,6,16635159
0,22.0,Headache,3,16635185
1,22.0,Depressed mood,6,16635185
2,22.0,Blindness unilateral,6,16635185
3,22.0,Malaise,6,16635185
4,22.0,Cholelithiasis,6,16635185
5,22.0,Balance disorder,6,16635185
0,22.0,Polyneuropathy,3,16635190
1,22.0,Cystitis,3,16635190
2,22.0,Neuropathy peripheral,3,16635190
3,22.0,Chills,1,16635190
4,22.0,Pain in extremity,3,16635190
5,22.0,Vomiting,1,16635190
6,22.0,Constipation,3,16635190
0,22.0,Superinfection,6,16635196
1,22.0,Weight decreased,6,16635196
2,22.0,Skin toxicity,6,16635196
3,22.0,Onychoclasis,6,16635196
4,22.0,Haemoglobin decreased,6,16635196
5,22.0,Nephritic syndrome,6,16635196
6,22.0,Abdominal pain,1,16635196
7,22.0,Nephrolithiasis,1,16635196
8,22.0,Renal cancer,6,16635196
9,22.0,Malignant neoplasm progression,6,16635196
10,22.0,Aphthous ulcer,6,16635196
11,22.0,Haematuria,6,16635196
12,22.0,Pyelonephritis acute,1,16635196
0,22.0,Headache,3,16635203
1,22.0,Diarrhoea,3,16635203
2,22.0,Depression,3,16635203
3,22.0,Weight increased,3,16635203
4,22.0,Gastrointestinal sounds abnormal,3,16635203
5,22.0,Abdominal discomfort,3,16635203
0,22.0,Alopecia,6,16635204
0,22.0,Alopecia,3,16635207
1,22.0,Fatigue,3,16635207
2,22.0,Constipation,6,16635207
0,22.0,Myalgia,6,16635208
1,22.0,Back pain,6,16635208
2,22.0,Condition aggravated,6,16635208
3,22.0,Arthralgia,6,16635208
0,22.0,Pruritus,3,16635209
0,22.0,Dysmenorrhoea,6,16635216
1,22.0,Metrorrhagia,6,16635216
2,22.0,Weight increased,6,16635216
3,22.0,Somnolence,6,16635216
4,22.0,Fatigue,6,16635216
0,22.0,Hot flush,3,16635218
1,22.0,Arthralgia,3,16635218
2,22.0,Alopecia,3,16635218
0,22.0,Hot flush,3,16635222
1,22.0,Urinary tract infection,3,16635222
0,22.0,Adverse event,6,16635223
0,22.0,Fatigue,1,16635239
1,22.0,Blood creatine phosphokinase increased,1,16635239
0,22.0,Hepatotoxicity,1,16635257
0,22.0,Renal impairment,3,16635263
0,22.0,Bone marrow failure,2,16635275
0,22.0,Perforation,6,16635281
0,22.0,Myelolipoma,6,16635282
1,22.0,Neurogenic bladder,6,16635282
2,22.0,Volvulus,6,16635282
0,22.0,Lung infection,5,16635318
1,22.0,Haemoglobin decreased,5,16635318
2,22.0,Feeding disorder,6,16635318
0,22.0,Tremor,1,16635325
1,22.0,Hyperventilation,1,16635325
2,22.0,Diplopia,1,16635325
3,22.0,Muscle rigidity,1,16635325
0,22.0,Renal impairment,3,16635347
1,22.0,Blood bilirubin increased,2,16635347
0,22.0,Viral infection,1,16635348
0,22.0,Atrial fibrillation,6,16635360
1,22.0,Tachycardia,6,16635360
0,22.1,Left ventricular dysfunction,2,16635363
1,22.1,Bundle branch block left,2,16635363
2,22.1,Congestive cardiomyopathy,2,16635363
3,22.1,Coronary artery disease,2,16635363
4,22.1,Cardiac failure chronic,2,16635363
5,22.1,Mitral valve incompetence,2,16635363
0,22.0,Diabetes mellitus,3,16635376
1,22.0,Hypertriglyceridaemia,3,16635376
2,22.0,Myocardial infarction,1,16635376
0,22.0,Obliterative bronchiolitis,6,16635378
1,22.0,Pulmonary arterial hypertension,6,16635378
0,22.0,Nausea,1,16635385
1,22.0,Lung disorder,6,16635385
2,22.0,Vomiting,1,16635385
3,22.0,Nasopharyngitis,6,16635385
4,22.0,Multiple organ dysfunction syndrome,5,16635385
5,22.0,Red blood cell count decreased,6,16635385
0,22.0,Renal failure,5,16635390
1,22.0,Ascites,5,16635390
2,22.0,Drug ineffective,6,16635390
3,22.0,Intestinal obstruction,5,16635390
4,22.0,Ileus,5,16635390
0,22.0,Malignant neoplasm progression,5,16635391
0,22.0,Ascites,5,16635393
0,22.0,Malignant neoplasm progression,5,16635397
0,22.0,Thyroid mass,6,16635425
1,22.0,Off label use,6,16635425
2,22.0,Metastases to bone,6,16635425
0,22.0,Atrial fibrillation,4,16635428
1,22.0,Cardiac failure,4,16635428
0,22.0,Cardiac failure,5,16635442
0,22.0,Diarrhoea,1,16635449
1,22.0,Renal pain,6,16635449
2,22.0,Constipation,6,16635449
3,22.0,Vomiting,1,16635449
4,22.0,Nausea,1,16635449
0,22.0,Azotaemia,6,16635451
0,22.0,Decreased activity,6,16635453
1,22.0,Lymphocyte count decreased,6,16635453
2,22.0,Skin disorder,6,16635453
3,22.0,Nail disorder,6,16635453
0,22.0,Bone marrow failure,1,16635454
1,22.0,Bone marrow failure,1,16635454
2,22.0,Bone marrow failure,2,16635454
0,22.0,Myocardial infarction,1,16635459
1,22.0,Diabetes mellitus,3,16635459
2,22.0,Hypertriglyceridaemia,3,16635459
0,22.1,Malignant neoplasm progression,5,16635464
0,22.0,Mucosal inflammation,6,16635471
1,22.0,Pneumonitis,6,16635471
2,22.0,Proteinuria,6,16635471
3,22.0,Rash,6,16635471
0,22.0,Rash,6,16635476
0,22.0,Anaphylactic reaction,1,16635488
0,22.0,Somnolence,3,16635500
1,22.0,Skin exfoliation,3,16635500
2,22.0,Vision blurred,1,16635500
3,22.0,Onychoclasis,3,16635500
4,22.0,Dyspnoea,3,16635500
5,22.0,Weight decreased,3,16635500
0,22.0,Onycholysis,1,16635506
1,22.0,Pseudomonas infection,1,16635506
0,22.0,Application site rash,1,16635529
1,22.0,Application site exfoliation,1,16635529
0,22.0,Metastases to liver,6,16635531
1,22.0,Breast cancer,3,16635531
0,22.0,Hepatic cirrhosis,2,16635541
1,22.0,Oedema,2,16635541
0,22.0,Cardiomyopathy,6,16635551
0,22.0,Lung disorder,2,16635554
0,22.0,Pain in extremity,2,16635567
1,22.0,Gait inability,6,16635567
2,22.0,Condition aggravated,6,16635567
3,22.0,Fall,6,16635567
0,22.0,Ascites,6,16635593
1,22.0,Ileus,6,16635593
2,22.0,White blood cell disorder,6,16635593
3,22.0,Malignant neoplasm progression,5,16635593
4,22.0,Anaemia,6,16635593
0,22.0,Ascites,5,16635594
1,22.0,Metastasis,5,16635594
2,22.0,Drug ineffective,6,16635594
0,22.0,Metastases to meninges,5,16635595
0,22.0,Ovarian epithelial cancer recurrent,6,16635596
1,22.0,Full blood count decreased,5,16635596
2,22.0,Malignant neoplasm progression,5,16635596
3,22.0,Renal failure,6,16635596
0,22.0,Ileus,5,16635597
1,22.0,Asthenia,5,16635597
2,22.0,Drug intolerance,3,16635597
3,22.0,Malignant neoplasm progression,5,16635597
0,22.0,Death,5,16635598
0,22.0,Malignant neoplasm progression,5,16635601
0,22.0,Malignant neoplasm progression,5,16635665
0,22.0,Pseudomonas infection,1,16635702
1,22.0,Onycholysis,1,16635702
0,22.0,Malignant neoplasm progression,5,16635729
0,22.0,Abdominal distension,5,16635736
1,22.0,Intra-abdominal fluid collection,5,16635736
2,22.0,Malignant neoplasm progression,5,16635736
0,22.0,Metastasis,5,16635772
1,22.0,Malignant neoplasm progression,5,16635772
0,22.0,Anaemia,6,16635779
0,22.0,Dyspnoea,,16635834
0,22.0,Death,,16635839
0,22.0,No adverse event,6,16635864
0,22.0,Vomiting,6,16635871
1,22.0,Therapeutic product effect decreased,6,16635871
0,22.0,Malignant neoplasm progression,5,16635872
0,22.0,Breast cancer metastatic,6,16635873
1,22.0,Malignant neoplasm progression,6,16635873
0,22.1,Lung abscess,1,16635924
0,22.0,Interstitial lung disease,2,16635949
0,22.0,Osteomyelitis,6,16635953
1,22.0,Bone sequestrum,6,16635953
0,22.0,Intentional product misuse,6,16635989
1,22.0,Nausea,6,16635989
0,22.1,Pain,1,16636049
1,22.1,Incorrect dose administered,6,16636049
2,22.1,Treatment noncompliance,6,16636049
0,22.0,Drug ineffective,6,16636057
1,22.0,Prostatic specific antigen increased,6,16636057
0,22.0,Prostatic specific antigen increased,3,16636063
1,22.0,Blood alkaline phosphatase increased,3,16636063
2,22.0,Drug ineffective,6,16636063
0,22.0,Hair disorder,3,16636074
1,22.0,Madarosis,3,16636074
2,22.0,Hair texture abnormal,3,16636074
3,22.0,Hair colour changes,3,16636074
4,22.0,Alopecia,3,16636074
0,22.0,Cystitis,6,16636085
0,22.0,Alopecia,3,16636096
1,22.0,Hair disorder,3,16636096
2,22.0,Madarosis,3,16636096
3,22.0,Hair colour changes,3,16636096
4,22.0,Dermal cyst,3,16636096
5,22.0,Anxiety,6,16636096
6,22.0,Hair texture abnormal,3,16636096
0,22.0,Neoplasm progression,6,16636098
0,22.1,Hair texture abnormal,3,16636100
1,22.1,Hair colour changes,3,16636100
2,22.1,Hair disorder,3,16636100
3,22.1,Alopecia,3,16636100
4,22.1,Madarosis,3,16636100
0,22.1,Therapy cessation,6,16636131
0,22.1,Drug hypersensitivity,1,16636190
1,22.1,Full blood count decreased,1,16636190
2,22.1,Cough,1,16636190
3,22.1,Product dose omission,6,16636190
4,22.1,Circumstance or information capable of leading to medication error,6,16636190
0,22.0,Ovarian cancer metastatic,5,16636191
1,22.0,Drug ineffective,6,16636191
0,22.0,Anaemia,6,16636197
1,22.0,Malignant neoplasm progression,6,16636197
0,22.1,Urinary tract infection,1,16636206
1,22.1,Fatigue,6,16636206
2,22.1,Neoplasm progression,6,16636206
3,22.1,Body height decreased,6,16636206
4,22.1,Malaise,6,16636206
0,22.0,Ileus,5,16636228
1,22.0,Ascites,5,16636228
0,22.0,Chest discomfort,1,16636286
1,22.0,Vertigo,1,16636286
2,22.0,Oxygen saturation decreased,1,16636286
3,22.0,Infusion related reaction,1,16636286
4,22.0,Back pain,1,16636286
5,22.0,Dyspnoea,1,16636286
0,22.1,Madarosis,3,16636341
1,22.1,Hair texture abnormal,3,16636341
2,22.1,Alopecia,3,16636341
3,22.1,Hair disorder,3,16636341
4,22.1,Hair colour changes,3,16636341
0,22.1,Speech disorder,6,16636425
1,22.1,Dyspnoea,6,16636425
0,22.0,Body height decreased,6,16636435
0,22.0,Back pain,,16636437
1,22.0,Muscle spasms,,16636437
2,22.0,Pain in extremity,,16636437
0,22.1,Somnolence,6,16636463
1,22.1,Memory impairment,6,16636463
2,22.1,Malaise,6,16636463
0,22.0,Electrolyte imbalance,,16636563
1,22.0,Hypocalcaemia,3,16636563
2,22.0,Anaemia,3,16636563
0,22.0,Dizziness,6,16636584
1,22.0,Malaise,6,16636584
2,22.0,Disease progression,1,16636584
0,22.0,Pneumonitis,6,16636586
1,22.0,Disease recurrence,3,16636586
0,22.0,Cardiac failure,1,16636592
0,22.0,Renal failure,5,16636600
1,22.0,Hepatic failure,5,16636600
0,22.0,Splenic rupture,,16636602
1,22.0,Hot flush,,16636602
0,22.0,Neutrophil count decreased,1,16636613
1,22.0,Neuropathy peripheral,2,16636613
0,22.0,Neutropenia,2,16636663
0,22.0,Malignant neoplasm progression,3,16636669
1,22.0,Death,5,16636669
2,22.0,Scleroderma,3,16636669
3,22.0,Neuropathy peripheral,3,16636669
4,22.0,Raynaud^s phenomenon,3,16636669
5,22.0,Restrictive pulmonary disease,3,16636669
0,22.0,Leukopenia,,16636728
0,22.0,Pneumonia,6,16636791
1,22.0,Abdominal pain upper,6,16636791
2,22.0,Decreased appetite,6,16636791
3,22.0,Concomitant disease aggravated,3,16636791
4,22.0,Pyrexia,6,16636791
5,22.0,Bile duct obstruction,3,16636791
6,22.0,Hepatotoxicity,6,16636791
7,22.0,Weight decreased,6,16636791
8,22.0,Malaise,6,16636791
9,22.0,Chills,6,16636791
0,22.0,Vulvovaginal pruritus,6,16636809
1,22.0,Vulvovaginal pain,6,16636809
2,22.0,Unevaluable event,6,16636809
3,22.0,Rash pruritic,6,16636809
0,22.0,Asthenia,6,16636902
1,22.0,Renal failure,2,16636902
2,22.0,Renal failure,1,16636902
3,22.0,Transaminases increased,3,16636902
4,22.0,Renal failure,1,16636902
5,22.0,Nausea,3,16636902
0,22.0,Haemorrhagic disorder,6,16636946
1,22.0,Cerebral infarction,6,16636946
2,22.0,Gastrointestinal haemorrhage,6,16636946
0,22.0,Cardiac failure,6,16636965
0,22.0,Abdominal distension,3,16636973
1,22.0,Feeding disorder,5,16636973
2,22.0,Vomiting,3,16636973
3,22.0,Recurrent cancer,5,16636973
4,22.0,Haematemesis,5,16636973
5,22.0,Cardiac failure,5,16636973
6,22.0,Hepatic function abnormal,3,16636973
0,22.0,Gallbladder enlargement,6,16636974
1,22.0,Uterine leiomyoma,6,16636974
2,22.0,Malignant neoplasm progression,6,16636974
3,22.0,Liver disorder,2,16636974
4,22.0,Interstitial lung disease,1,16636974
0,22.0,Adverse event,1,16636984
0,22.0,Limb immobilisation,,16636992
0,22.0,Cardiac failure acute,2,16637000
1,22.0,Oedema peripheral,2,16637000
2,22.0,Acute pulmonary oedema,1,16637000
0,22.0,Anaphylactic shock,1,16637046
0,22.0,Cardiac failure,1,16637163
1,22.0,Cardiotoxicity,1,16637163
0,22.0,Dyspnoea,5,16637168
0,22.0,Ovarian cancer metastatic,5,16637169
1,22.0,Ovarian cancer recurrent,5,16637169
0,22.0,Malignant neoplasm progression,5,16637172
0,22.0,Decubitus ulcer,3,16637180
0,22.0,White blood cell count decreased,6,16637182
1,22.0,Death,5,16637182
0,22.0,Completed suicide,5,16637184
1,22.0,White blood cell count decreased,6,16637184
0,22.0,Neoplasm progression,6,16637241
1,22.0,Death,5,16637241
0,22.0,Neutrophil count decreased,6,16637244
1,22.0,Death,5,16637244
2,22.0,Neoplasm progression,6,16637244
0,22.0,Death,5,16637245
1,22.0,Neoplasm progression,6,16637245
0,22.0,Malignant neoplasm progression,5,16637313
0,22.0,Seizure,6,16637314
1,22.0,Intentional product misuse,6,16637314
2,22.0,Ileus,6,16637314
3,22.0,Weight decreased,6,16637314
4,22.0,Metastases to lymph nodes,6,16637314
5,22.0,Anaemia,6,16637314
6,22.0,Vomiting,6,16637314
7,22.0,Metastases to central nervous system,5,16637314
8,22.0,Speech disorder,6,16637314
9,22.0,Malignant neoplasm progression,5,16637314
0,22.0,Neutrophil count decreased,6,16637321
1,22.0,Aspartate aminotransferase increased,6,16637321
2,22.0,Carbohydrate antigen 15-3 increased,6,16637321
3,22.0,White blood cell count decreased,6,16637321
4,22.0,Neoplasm progression,6,16637321
5,22.0,Carcinoembryonic antigen increased,6,16637321
6,22.0,Blood bilirubin increased,6,16637321
7,22.0,Alanine aminotransferase increased,6,16637321
0,22.0,Purpura,6,16637327
1,22.0,Haemorrhagic disorder,6,16637327
2,22.0,Therapy partial responder,6,16637327
0,22.0,Rash generalised,6,16637383
0,22.0,Pancreatitis acute,,16637452
0,22.0,Liver function test increased,,16637463
1,22.0,Therapy change,,16637463
0,22.0,Death,5,16637496
0,22.1,Recurrent cancer,6,16637675
1,22.1,Off label use,6,16637675
2,22.1,Skin exfoliation,6,16637675
3,22.1,Renal haemorrhage,6,16637675
0,22.0,Death,5,16637725
0,22.0,Cerebral infarction,5,16637726
0,22.0,Feeding disorder,5,16637728
1,22.0,Malignant neoplasm progression,6,16637728
0,22.1,Dizziness,2,16637743
1,22.1,Depressive symptom,1,16637743
2,22.1,Stomatitis,2,16637743
3,22.1,Interstitial lung disease,2,16637743
4,22.1,Malaise,1,16637743
5,22.1,Nausea,2,16637743
6,22.1,Oxygen saturation decreased,1,16637743
7,22.1,Vomiting,2,16637743
8,22.1,Oedema peripheral,2,16637743
0,22.0,Carcinoembryonic antigen increased,6,16637745
1,22.0,Vomiting,6,16637745
2,22.0,Drug ineffective,6,16637745
3,22.0,Malignant neoplasm progression,6,16637745
4,22.0,Ileus,5,16637745
5,22.0,Nausea,6,16637745
0,22.0,Angina pectoris,4,16637752
1,22.0,Pancytopenia,4,16637752
2,22.0,Product use in unapproved indication,6,16637752
3,22.0,Off label use,6,16637752
0,22.1,Second primary malignancy,6,16637760
1,22.1,Lung carcinoma cell type unspecified stage IV,6,16637760
0,22.1,Condition aggravated,3,16637771
1,22.1,Decreased appetite,1,16637771
2,22.1,Fatigue,1,16637771
3,22.1,Diarrhoea,2,16637771
4,22.1,Malaise,1,16637771
5,22.1,Anxiety,3,16637771
6,22.1,Disease progression,6,16637771
7,22.1,Dehydration,1,16637771
8,22.1,Feeling abnormal,3,16637771
9,22.1,Asthenia,3,16637771
10,22.1,Nausea,1,16637771
0,22.0,Death,5,16637774
0,22.1,Vulvovaginitis,1,16637776
0,22.0,Death,5,16637814
0,22.0,Death,5,16637827
0,22.0,Renal failure,5,16637828
1,22.0,Ileus,5,16637828
0,22.0,Oropharyngeal pain,5,16637832
1,22.0,Anaemia,5,16637832
2,22.0,Platelet count decreased,5,16637832
3,22.0,Nasopharyngitis,5,16637832
4,22.0,Haemorrhage,5,16637832
5,22.0,Hypophagia,5,16637832
6,22.0,Malignant neoplasm progression,6,16637832
7,22.0,Pyrexia,5,16637832
0,22.0,Renal failure,5,16637833
1,22.0,Infection,5,16637833
0,22.0,Platelet count decreased,5,16637836
1,22.0,Metastasis,6,16637836
2,22.0,Asthma,5,16637836
3,22.0,Oropharyngeal pain,5,16637836
4,22.0,Haematochezia,5,16637836
5,22.0,Malignant neoplasm progression,6,16637836
6,22.0,Cachexia,5,16637836
7,22.0,Malaise,5,16637836
8,22.0,Decreased appetite,5,16637836
9,22.0,White blood cell count decreased,5,16637836
10,22.0,Multiple organ dysfunction syndrome,5,16637836
11,22.0,Asthenia,5,16637836
12,22.0,Dyspnoea,5,16637836
13,22.0,Nasopharyngitis,5,16637836
0,22.0,Death,5,16637837
0,22.0,Ascites,6,16637839
1,22.0,Pain,6,16637839
2,22.0,Dyspnoea,6,16637839
3,22.0,Pleural effusion,6,16637839
4,22.0,Cardiac failure,5,16637839
5,22.0,Renal failure,5,16637839
6,22.0,Discomfort,6,16637839
0,22.0,Malignant neoplasm progression,5,16637843
1,22.0,Cardiac failure,5,16637843
2,22.0,Platelet count decreased,3,16637843
3,22.0,Product dose omission,6,16637843
4,22.0,Ileus,5,16637843
5,22.0,Lung infection,5,16637843
6,22.0,Pyrexia,3,16637843
7,22.0,Constipation,6,16637843
0,22.0,Haemorrhoids,6,16637890
1,22.0,Rectal haemorrhage,6,16637890
0,22.0,Adverse event,6,16637898
1,22.0,Cholangiostomy,6,16637898
2,22.0,Biloma,6,16637898
3,22.0,Adverse event,6,16637898
4,22.0,Packed red blood cell transfusion,6,16637898
5,22.0,Product use in unapproved indication,6,16637898
6,22.0,Packed red blood cell transfusion,6,16637898
0,22.0,Renal failure,2,16637904
0,22.1,Erythema multiforme,1,16638004
1,22.1,Blood alkaline phosphatase increased,1,16638004
0,22.0,Malignant neoplasm progression,5,16638005
1,22.0,Metastases to liver,5,16638005
0,22.0,Hepatitis,2,16638009
1,22.0,Alanine aminotransferase increased,2,16638009
0,22.0,Hypothyroidism,6,16638016
1,22.0,Lipase increased,6,16638016
2,22.0,Anaemia,6,16638016
3,22.0,Immune-mediated adverse reaction,6,16638016
4,22.0,Therapy partial responder,6,16638016
5,22.0,Rash,6,16638016
0,22.0,Pruritus,3,16638025
0,22.1,Pharyngitis bacterial,6,16638047
1,22.1,Haematocrit decreased,6,16638047
2,22.1,Aortic valve incompetence,6,16638047
3,22.1,Metastases to skin,6,16638047
4,22.1,Oropharyngeal discomfort,6,16638047
5,22.1,Aspartate aminotransferase increased,6,16638047
6,22.1,Skin discolouration,6,16638047
7,22.1,Bronchitis,6,16638047
8,22.1,Nausea,1,16638047
9,22.1,Neoplasm skin,6,16638047
10,22.1,Productive cough,6,16638047
11,22.1,Platelet count increased,6,16638047
12,22.1,Mitral valve incompetence,6,16638047
13,22.1,Blood chloride decreased,6,16638047
14,22.1,Benign neoplasm of skin,6,16638047
15,22.1,Lower respiratory tract infection bacterial,6,16638047
16,22.1,Angina pectoris,6,16638047
17,22.1,Nasopharyngitis,6,16638047
18,22.1,Coronary artery disease,6,16638047
19,22.1,Blood glucose increased,6,16638047
20,22.1,Blood sodium decreased,6,16638047
21,22.1,Hyponatraemia,6,16638047
22,22.1,Blood pressure decreased,6,16638047
23,22.1,Tooth fracture,6,16638047
24,22.1,Actinic keratosis,6,16638047
25,22.1,Normocytic anaemia,6,16638047
26,22.1,Red blood cell count decreased,6,16638047
27,22.1,Haemoglobin decreased,6,16638047
28,22.1,Glomerular filtration rate decreased,6,16638047
29,22.1,Red cell distribution width increased,6,16638047
0,22.0,Aortic aneurysm,6,16638059
1,22.0,Thrombosis,6,16638059
2,22.0,Drug interaction,1,16638059
3,22.0,Cerebrovascular accident,1,16638059
0,22.0,Breast cancer,6,16638080
1,22.0,Metastases to bone,6,16638080
2,22.0,Malignant pleural effusion,6,16638080
3,22.0,Malignant neoplasm progression,6,16638080
0,22.0,Malignant neoplasm progression,6,16638099
1,22.0,Dyspepsia,3,16638099
2,22.0,Metastasis,5,16638099
3,22.0,Feeding disorder,5,16638099
0,22.0,Metastasis,5,16638101
0,22.0,Asthenia,5,16638102
1,22.0,Malignant neoplasm progression,5,16638102
2,22.0,Blood count abnormal,5,16638102
0,22.0,Drug interaction,6,16638118
1,22.0,Abdominal discomfort,6,16638118
2,22.0,Decreased appetite,6,16638118
3,22.0,Nausea,6,16638118
4,22.0,Seizure,6,16638118
0,22.0,Gastrointestinal ulcer,1,16638155
1,22.0,Fistula of small intestine,1,16638155
0,22.0,Death,5,16638271
0,22.0,Blood test abnormal,5,16638273
1,22.0,Cerebral haemorrhage,5,16638273
0,22.0,Renal impairment,5,16638274
1,22.0,Malignant neoplasm progression,6,16638274
2,22.0,Hydrothorax,6,16638274
3,22.0,Ascites,6,16638274
4,22.0,Hydrocele female,6,16638274
5,22.0,Ileus,2,16638274
0,22.0,Malignant neoplasm progression,5,16638279
0,22.0,Malignant neoplasm progression,5,16638280
0,22.0,Neutropenia,1,16638291
1,22.0,Drug intolerance,6,16638291
2,22.0,Infusion related reaction,6,16638291
3,22.0,Toxicity to various agents,6,16638291
4,22.0,Haematochezia,6,16638291
5,22.0,Haemoglobin decreased,6,16638291
6,22.0,Headache,6,16638291
7,22.0,Drug hypersensitivity,6,16638291
0,22.0,Malaise,2,16638294
1,22.0,Hypertension,6,16638294
0,22.0,Pericardial effusion,1,16638297
0,22.0,Myelodysplastic syndrome,3,16638299
0,22.0,Malignant neoplasm progression,5,16638330
1,22.0,Oral candidiasis,6,16638330
2,22.0,Angular cheilitis,6,16638330
3,22.0,Stomatitis,6,16638330
4,22.0,Febrile neutropenia,3,16638330
0,22.0,Hypophagia,5,16638360
0,22.0,Malignant neoplasm progression,6,16638362
1,22.0,Anaemia,6,16638362
2,22.0,Neutrophil count decreased,6,16638362
0,22.0,Death,5,16638365
0,22.0,Decreased appetite,3,16638378
1,22.0,Eating disorder,1,16638378
2,22.0,Weight decreased,,16638378
3,22.0,Nausea,3,16638378
4,22.0,Asthenia,2,16638378
5,22.0,Diarrhoea,3,16638378
6,22.0,Off label use,,16638378
0,22.0,Bone lesion,6,16638398
1,22.0,Drug diversion,6,16638398
2,22.0,Treatment failure,6,16638398
3,22.0,Anaemia,6,16638398
4,22.0,Asthenia,6,16638398
0,22.0,Atelectasis,6,16638420
1,22.0,Interstitial lung disease,5,16638420
2,22.0,Malignant neoplasm progression,5,16638420
3,22.0,Metastases to liver,6,16638420
0,22.0,Haemorrhage,3,16638426
1,22.0,Haemoglobin decreased,3,16638426
2,22.0,Therapeutic product effect decreased,3,16638426
3,22.0,Ileus,3,16638426
4,22.0,Dyspnoea,5,16638426
5,22.0,Feeding disorder,6,16638426
6,22.0,Haematochezia,5,16638426
7,22.0,Respiratory failure,5,16638426
8,22.0,Asthma,6,16638426
0,22.0,Malignant neoplasm progression,5,16638427
0,22.0,Malignant neoplasm progression,5,16638428
0,22.0,Liver function test increased,1,16638430
1,22.0,Autoimmune hepatitis,6,16638430
2,22.0,Cardiac disorder,6,16638430
0,22.0,Death,5,16638470
0,22.0,Death,5,16638471
0,22.0,Vocal cord paralysis,6,16638473
0,22.0,Myalgia,6,16638533
1,22.0,Bone pain,6,16638533
2,22.0,Death,5,16638533
0,22.0,Ileus,5,16638548
1,22.0,Feeding disorder,5,16638548
2,22.0,Malignant neoplasm progression,6,16638548
0,22.0,Underdose,6,16638553
1,22.0,Skin haemorrhage,3,16638553
2,22.0,Rash,3,16638553
3,22.0,Treatment noncompliance,6,16638553
0,22.0,Ileus,5,16638554
1,22.0,Metastatic neoplasm,5,16638554
2,22.0,Malignant neoplasm progression,5,16638554
0,22.0,Metastasis,5,16638555
0,22.0,Hepatic failure,5,16638556
0,22.0,Neutrophil count decreased,6,16638619
1,22.0,Neoplasm progression,6,16638619
2,22.0,Death,5,16638619
0,22.0,Pyrexia,6,16638647
1,22.0,Metastases to bone,6,16638647
2,22.0,Coma,6,16638647
3,22.0,Balance disorder,6,16638647
4,22.0,Somnolence,6,16638647
5,22.0,Asthenia,6,16638647
6,22.0,Brain oedema,6,16638647
7,22.0,Anaemia,6,16638647
8,22.0,Metastases to central nervous system,5,16638647
9,22.0,Epilepsy,6,16638647
10,22.0,Dehydration,6,16638647
11,22.0,Malignant neoplasm progression,5,16638647
12,22.0,Metastases to spine,6,16638647
13,22.0,Dysphagia,6,16638647
14,22.0,White blood cell count abnormal,6,16638647
0,22.0,Metastasis,5,16638648
0,22.0,Death,5,16638654
0,22.0,Paraesthesia oral,1,16638659
1,22.0,Loss of consciousness,6,16638659
2,22.0,Headache,1,16638659
3,22.0,Dizziness,1,16638659
4,22.0,Confusional state,6,16638659
5,22.0,Product dose omission,6,16638659
0,22.1,Rash,1,16638671
1,22.1,Epistaxis,1,16638671
2,22.1,Neuropathy peripheral,3,16638671
3,22.1,Anaemia,1,16638671
4,22.1,Dermatitis acneiform,1,16638671
5,22.1,Toxicity to various agents,6,16638671
6,22.1,Herpes simplex,1,16638671
7,22.1,Pain,6,16638671
8,22.1,Thrombocytopenia,6,16638671
9,22.1,Nausea,1,16638671
10,22.1,Hypertrichosis,1,16638671
11,22.1,Product use in unapproved indication,6,16638671
0,22.0,Malignant neoplasm progression,5,16638732
0,22.0,Ileus,5,16638733
1,22.0,Intestinal metastasis,5,16638733
2,22.0,Metastases to abdominal cavity,5,16638733
3,22.0,Renal disorder,6,16638733
4,22.0,Hypophagia,5,16638733
5,22.0,Dyspepsia,5,16638733
0,22.1,Pancytopenia,6,16638734
1,22.1,Malignant neoplasm progression,6,16638734
2,22.1,Anaemia,6,16638734
3,22.1,Renal impairment,6,16638734
0,22.0,Death,5,16638736
0,22.0,Spinal pain,1,16638755
1,22.0,Erythema,1,16638755
2,22.0,Vomiting,1,16638755
3,22.0,Abdominal pain,1,16638755
4,22.0,Dyspnoea,1,16638755
0,22.1,Bronchitis,3,16638780
1,22.1,Upper-airway cough syndrome,6,16638780
2,22.1,Upper respiratory tract infection,1,16638780
3,22.1,Bone marrow failure,3,16638780
4,22.1,Chest pain,6,16638780
5,22.1,Fatigue,3,16638780
6,22.1,Abdominal discomfort,3,16638780
7,22.1,Musculoskeletal chest pain,6,16638780
8,22.1,Headache,6,16638780
9,22.1,Alopecia,6,16638780
10,22.1,Cough,6,16638780
11,22.1,Increased tendency to bruise,6,16638780
12,22.1,Hypotension,6,16638780
13,22.1,Dizziness,6,16638780
14,22.1,White blood cell count decreased,6,16638780
0,22.0,Death,5,16638807
0,22.0,Ovarian epithelial cancer recurrent,5,16638817
1,22.0,Metastasis,5,16638817
0,22.0,Metastases to central nervous system,5,16638849
1,22.0,Ileus,6,16638849
0,22.0,Neutrophil count decreased,1,16638892
1,22.0,Neuropathy peripheral,1,16638892
0,22.0,Malignant neoplasm progression,5,16638896
1,22.0,Ascites,5,16638896
2,22.0,Insomnia,6,16638896
0,22.0,Ovarian epithelial cancer metastatic,5,16638897
0,22.0,Malignant neoplasm progression,5,16638899
0,22.0,Pathological fracture,2,16638906
0,22.0,Metastases to central nervous system,3,16638934
1,22.0,Metastases to lung,3,16638934
2,22.0,General physical health deterioration,3,16638934
3,22.0,Death,5,16638934
4,22.0,Neutropenia,6,16638934
5,22.0,Hepatic lesion,3,16638934
0,22.0,Drug interaction,5,16638943
1,22.0,Toxicity to various agents,5,16638943
0,22.1,Colitis,1,16639027
0,22.0,Malignant neoplasm progression,6,16639040
1,22.0,Breast cancer metastatic,6,16639040
0,22.0,Erythema,1,16639062
1,22.0,Renal impairment,1,16639062
0,22.0,Cardiac arrest,5,16639107
1,22.0,Stomatitis,1,16639107
2,22.0,Taste disorder,3,16639107
3,22.0,Fatigue,6,16639107
0,22.1,Pruritus,1,16639113
1,22.1,Bone pain,6,16639113
2,22.1,Skin exfoliation,1,16639113
3,22.1,Asthenia,6,16639113
4,22.1,Confusional state,6,16639113
5,22.1,Pain,6,16639113
6,22.1,Rash,1,16639113
7,22.1,Eye disorder,3,16639113
8,22.1,Pain in extremity,3,16639113
9,22.1,Headache,6,16639113
10,22.1,Nasopharyngitis,3,16639113
11,22.1,Alopecia,6,16639113
12,22.1,Fatigue,3,16639113
13,22.1,Amnesia,3,16639113
14,22.1,Mouth swelling,3,16639113
15,22.1,Vomiting,6,16639113
0,22.0,Product supply issue,6,16639114
1,22.0,No adverse event,6,16639114
2,22.0,Product dose omission,6,16639114
0,22.0,Pulmonary toxicity,2,16639149
1,22.0,Pneumonitis,1,16639149
0,22.0,Polyneuropathy,6,16639158
1,22.0,Diarrhoea,6,16639158
2,22.0,Neutropenia,3,16639158
3,22.0,Drug intolerance,6,16639158
0,22.0,Visual impairment,6,16639160
1,22.0,Breast mass,6,16639160
2,22.0,Neoplasm recurrence,6,16639160
3,22.0,Neoplasm progression,6,16639160
4,22.0,Drug intolerance,6,16639160
5,22.0,Breast enlargement,6,16639160
0,22.0,Pyrexia,1,16639161
0,22.0,Febrile neutropenia,6,16639165
1,22.0,Thrombocytopenia,6,16639165
0,22.0,Shock haemorrhagic,1,16639170
1,22.0,Hepatotoxicity,1,16639170
2,22.0,Plasma cell myeloma,1,16639170
3,22.0,Hypothyroidism,1,16639170
0,22.0,Malaise,2,16639175
1,22.0,Gastroenteritis viral,6,16639175
2,22.0,Colitis,2,16639175
3,22.0,Dehydration,2,16639175
0,22.0,Hair disorder,6,16639180
1,22.0,Hair texture abnormal,6,16639180
2,22.0,Alopecia,3,16639180
3,22.0,Hair colour changes,6,16639180
4,22.0,Madarosis,3,16639180
0,22.0,Abdominal rigidity,1,16639251
1,22.0,Cholestatic liver injury,2,16639251
2,22.0,Vomiting,1,16639251
3,22.0,Erythema,1,16639251
